Today: 8 February 2026
Subscribe

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius (NBIS) stock ticks up as AI names rebound — Rubin rollout and earnings are the next tests

Nebius shares rose 1.2% to $98.48 Friday afternoon after swinging above $104 earlier in the session. The move followed gains in chip stocks and AI infrastructure names, with Nvidia up 0.5% and Applied Digital jumping over 17%. Traders are watching Nebius’ plans to offer Nvidia’s Rubin GPUs in late 2026 and its next earnings report, expected Feb. 18.
9 January 2026
··
Cisco stock today: CSCO ticks up as switch reboot reports and security patch hit headlines

Cisco stock today: CSCO ticks up as switch reboot reports and security patch hit headlines

Cisco shares rose 0.5% to $74.32 Friday despite reports of switch glitches causing reboot loops and a new security update for its Identity Services Engine. Some administrators reported workarounds for the switch issue, while Cisco said no exploitation of the security flaw had been observed. The stock traded between $73.17 and $74.32 during the session. Investors await further updates from the company.
9 January 2026
·
Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

Texas Instruments stock ticks up as chipmakers rally — what could move TXN next

Texas Instruments shares rose 1% to $190.24 Friday as chipmakers rallied, with the Philadelphia Semiconductor Index up 2.6% and the S&P 500 hitting a record. U.S. nonfarm payrolls increased by 50,000 in December, while unemployment dipped to 4.4%. Taiwan Semiconductor reported a 20% jump in Q4 revenue, beating forecasts. Texas Instruments will report Q4 earnings on Jan. 27.
9 January 2026
······
Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

Constellation Energy stock jumps as TD Cowen turns bullish, Meta nuclear deals lift power names

Constellation Energy shares climbed 5.6% to $340.51 Friday after TD Cowen began coverage with a buy rating and $440 target. The move followed Constellation’s completed acquisition of Calpine, creating the largest U.S. electricity producer. Meta’s 20-year nuclear power deals lifted sector peers. The DOJ cleared the Calpine deal last month with required divestitures.
9 January 2026
···
Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola stock rises as soft U.S. jobs report boosts staples; CPI, Fed and earnings ahead

Coca-Cola shares rose 1.4% to $70.33 Friday, topping $70 as investors favored consumer staples after a weaker-than-expected U.S. jobs report. Nonfarm payrolls increased by 50,000 in December, missing forecasts, while unemployment dipped to 4.4%. The Consumer Staples Select Sector SPDR Fund gained 0.9%. Markets await the December CPI report on Jan. 13 and the Fed’s policy meeting later this month.
9 January 2026
···
P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

P&G stock edges up after Crest kids toothpaste deal; TD Cowen trims target ahead of Jan. 22 earnings

Procter & Gamble agreed to change Kid’s Crest toothpaste packaging and marketing after pressure from Texas Attorney General Ken Paxton, who cited concerns over dosing for children. New labels began rolling out Jan. 1, with P&G required to comply for five years. Shares rose 0.3% to $141.92 Friday. A private lawsuit over Kid’s Crest labels remains active in Chicago.
9 January 2026
··
AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

AST SpaceMobile stock snaps back near $100 as BofA lifts target after Scotiabank cut

AST SpaceMobile shares climbed 8.6% to $98.34 Friday after Bank of America raised its price target to $100, maintaining a Neutral rating. The rebound followed a sharp drop earlier in the week. Scotiabank downgraded the stock to Sector Underperform, citing high valuation and lack of retail customers. Investors await the next earnings report, expected March 2, for updates on satellite rollout and customer uptake.
9 January 2026
··
Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce stock slips as Spring ’26 AI release lands and traders weigh soft U.S. jobs data

Salesforce shares slipped 0.2% to $260.01 after unveiling its Spring ’26 product release, featuring new AI and automation tools, set to roll out from Feb. 23. U.S. payrolls rose by 50,000 in December, below forecasts, while unemployment fell to 4.4%. The S&P 500 hit a record intraday high after the jobs report. Fed funds futures priced in a 4.8% chance of a rate cut at the next Fed meeting.
9 January 2026
···
Accenture stock price today: ACN slips as jobs data resets rate bets, new retail AI push in focus

Accenture stock price today: ACN slips as jobs data resets rate bets, new retail AI push in focus

Accenture shares fell 0.6% to $280.15 Friday afternoon, trailing gains in the broader market after a weaker-than-expected U.S. jobs report. The company announced a new AI partnership with Profitmind and will demo the technology at the National Retail Federation event next week. Investors are watching for Accenture’s earnings call on March 19 and the Federal Reserve’s policy meeting Jan. 27-28.
9 January 2026
··
Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate (STX) stock rebounds toward $300 after Goldman target hike, earnings in focus

Seagate Technology rose 5.4% to $299.92 after Goldman Sachs raised its price target to $310, citing strong 2026 pricing forecasts. The gain followed a 7.7% drop the previous day. A U.S. appeals court revived Seagate’s antitrust claims against NHK Spring late Thursday. Seagate’s next earnings report is expected around Jan. 20, though the date is unconfirmed.
9 January 2026
····
Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark

Revolution Medicines stock rises as Merck buyout talks swirl; FDA designation adds another spark

Revolution Medicines shares rose 4.3% to $112.00 Friday after reports that Merck is in talks to buy the company for up to $32 billion. The FDA granted Breakthrough Therapy designation to Revolution’s KRAS-targeting lung cancer drug this week. AbbVie denied involvement in any deal. Revolution declined to comment on the takeover speculation.
9 January 2026
··
Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia stock holds steady after China H200 pay-upfront report — what AI investors watch next

Nvidia shares rose 0.1% to $185.31 Friday after Reuters reported the company now requires full upfront payment from Chinese buyers for H200 AI chips, with no cancellations or refunds allowed. Chinese tech firms have ordered over 2 million H200 chips, outstripping Nvidia’s inventory of about 700,000. Beijing has asked some firms to halt orders as it reviews conditions, even as U.S. export licenses are still pending.
9 January 2026
·
1 … 261 262 263 264 265 … 611

Stock Market Today

CBA share price: Commonwealth Bank stock steadies after ASX selloff as earnings loom

CBA share price: Commonwealth Bank stock steadies after ASX selloff as earnings loom

8 February 2026
Commonwealth Bank of Australia closed Friday down 0.23% at A$158.91, outperforming a 2.03% drop in the S&P/ASX 200. Investors await CBA’s half-year results on Feb. 11 and commentary from CEO Matt Comyn. The Reserve Bank’s recent cash-rate hike to 3.85% and upcoming mortgage repricing are in focus. CBA flagged A$68 million in provisions and A$53 million in non-recurring income items.
Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

Boeing stock jumps 2.6% to $243 — what Wall Street is watching before Monday

8 February 2026
Boeing shares closed up 2.6% at $243.03 Friday, buoyed by reports of possible major aircraft orders from Saudi Arabia and India. India’s trade minister said a $70–80 billion Boeing deal could be signed by March. Supply-chain delays and regulatory scrutiny remain key risks. Boeing’s chief engineer sold over 10,000 shares earlier in the week.
Go toTop